Abstract
This symposium summary, sponsored by the ASPET, was held at Experimental Biology 2015 on March 29, 2015, in Boston, Massachusetts. The symposium focused on: 1) the interactions of cytochrome P450s (P450s) with their redox partners; and 2) the role of the lipid membrane in their orientation and stabilization. Two presentations discussed the interactions of P450s with NADPH-P450 reductase (CPR) and cytochrome b5. First, solution nuclear magnetic resonance was used to compare the protein interactions that facilitated either the hydroxylase or lyase activities of CYP17A1. The lyase interaction was stimulated by the presence of b5 and 17α-hydroxypregnenolone, whereas the hydroxylase reaction was predominant in the absence of b5. The role of b5 was also shown in vivo by selective hepatic knockout of b5 from mice expressing CYP3A4 and CYP2D6; the lack of b5 caused a decrease in the clearance of several substrates. The role of the membrane on P450 orientation was examined using computational methods, showing that the proximal region of the P450 molecule faced the aqueous phase. The distal region, containing the substrate-access channel, was associated with the membrane. The interaction of NADPH-P450 reductase (CPR) with the membrane was also described, showing the ability of CPR to “helicopter” above the membrane. Finally, the endoplasmic reticulum (ER) was shown to be heterogeneous, having ordered membrane regions containing cholesterol and more disordered regions. Interestingly, two closely related P450s, CYP1A1 and CYP1A2, resided in different regions of the ER. The structural characteristics of their localization were examined. These studies emphasize the importance of P450 protein organization to their function.
Footnotes
- Received December 29, 2015.
- Accepted February 3, 2016.
This work was supported in part by National Institutes of Health [R01 GM076343, GM102505] to E.E.S.; [F32 GM103069] to D.F.E.; [GM110790] to J.P.J.; and [R01 ES004344\ and [P42 ES013648] to W.L.B.; the Ministry of Education, Youth and Sports of the Czech Republic, project LO1305 to M.O. and the Grant Agency of the Czech Republic, [P303/12/G163] to P.A; and Cancer Research UK Programme Grant [C4639/A10822] to C.R.W.
This report is a summary of a session at Experimental Biology 2015 sponsored by the Drug Metabolism Division of ASPET.
Emily E. Scott, C. Roland Wolf, Michal Otyepka, Sara C. Humphreys, and James R. Reed were speakers at the symposium and are considered co-first authors.
↵This article has supplemental material available at dmd.aspetjournals.org.
- Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|